Research ExplorerPublicationsRecommendations on the Use of Magnetic Resonance Imaging for...

Recommendations on the Use of Magnetic Resonance Imaging for Collaborative Multicenter Studies in Primary Sclerosing Cholangitis

Standard

Recommendations on the Use of Magnetic Resonance Imaging for Collaborative Multicenter Studies in Primary Sclerosing Cholangitis. / Ringe, Kristina I; Grigoriadis, Aristeidis; Halibasic, Emina; Wacker, Frank; Manns, Michael P; Schramm, Christoph; Lenzen, Henrike; MRI working group of the IPSCSG.

In: HEPATOLOGY, Vol. 69, No. 3, 03.2019, p. 1358-1359.

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Harvard

Ringe, KI, Grigoriadis, A, Halibasic, E, Wacker, F, Manns, MP, Schramm, C, Lenzen, H & MRI working group of the IPSCSG 2019, 'Recommendations on the Use of Magnetic Resonance Imaging for Collaborative Multicenter Studies in Primary Sclerosing Cholangitis', HEPATOLOGY, vol. 69, no. 3, pp. 1358-1359. https://doi.org/10.1002/hep.30276

APA

Ringe, K. I., Grigoriadis, A., Halibasic, E., Wacker, F., Manns, M. P., Schramm, C., Lenzen, H., & MRI working group of the IPSCSG (2019). Recommendations on the Use of Magnetic Resonance Imaging for Collaborative Multicenter Studies in Primary Sclerosing Cholangitis. HEPATOLOGY, 69(3), 1358-1359. https://doi.org/10.1002/hep.30276

Vancouver

Ringe KI, Grigoriadis A, Halibasic E, Wacker F, Manns MP, Schramm C et al. Recommendations on the Use of Magnetic Resonance Imaging for Collaborative Multicenter Studies in Primary Sclerosing Cholangitis. HEPATOLOGY. 2019 Mar;69(3):1358-1359. https://doi.org/10.1002/hep.30276

Bibtex

@article{753eeff74ccb46c88c6e67cba51b9f85,
title = "Recommendations on the Use of Magnetic Resonance Imaging for Collaborative Multicenter Studies in Primary Sclerosing Cholangitis",
abstract = "Recently, the MRI working group of the International PSC Study Group (IPSCSG) has published a position statement on the use of MRI regarding diagnosis and follow-up of PSC patients. These guidelines are intended for use by physicians in daily clinical routine. In addition, the group has outlined several areas of research, which need to be addressed in the near future. As PSC is a rare disease with the clinical outcome being determined by the development of end-stage liver disease and hepatobiliary malignancy. This article is protected by copyright. All rights reserved.",
keywords = "Letter",
author = "Ringe, {Kristina I} and Aristeidis Grigoriadis and Emina Halibasic and Frank Wacker and Manns, {Michael P} and Christoph Schramm and Henrike Lenzen and {MRI working group of the IPSCSG}",
note = "Letter",
year = "2019",
month = mar,
doi = "10.1002/hep.30276",
language = "English",
volume = "69",
pages = "1358--1359",
journal = "HEPATOLOGY",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

RIS

TY - JOUR

T1 - Recommendations on the Use of Magnetic Resonance Imaging for Collaborative Multicenter Studies in Primary Sclerosing Cholangitis

AU - Ringe, Kristina I

AU - Grigoriadis, Aristeidis

AU - Halibasic, Emina

AU - Wacker, Frank

AU - Manns, Michael P

AU - Schramm, Christoph

AU - Lenzen, Henrike

AU - MRI working group of the IPSCSG

N1 - Letter

PY - 2019/3

Y1 - 2019/3

N2 - Recently, the MRI working group of the International PSC Study Group (IPSCSG) has published a position statement on the use of MRI regarding diagnosis and follow-up of PSC patients. These guidelines are intended for use by physicians in daily clinical routine. In addition, the group has outlined several areas of research, which need to be addressed in the near future. As PSC is a rare disease with the clinical outcome being determined by the development of end-stage liver disease and hepatobiliary malignancy. This article is protected by copyright. All rights reserved.

AB - Recently, the MRI working group of the International PSC Study Group (IPSCSG) has published a position statement on the use of MRI regarding diagnosis and follow-up of PSC patients. These guidelines are intended for use by physicians in daily clinical routine. In addition, the group has outlined several areas of research, which need to be addressed in the near future. As PSC is a rare disease with the clinical outcome being determined by the development of end-stage liver disease and hepatobiliary malignancy. This article is protected by copyright. All rights reserved.

KW - Letter

U2 - 10.1002/hep.30276

DO - 10.1002/hep.30276

M3 - Other (editorial matter etc.)

C2 - 30222864

VL - 69

SP - 1358

EP - 1359

JO - HEPATOLOGY

JF - HEPATOLOGY

SN - 0270-9139

IS - 3

ER -